(Information sent by the signatory company)
LONDON, ON, Jan. 8, 2024 /PRNewswire/ — Alimentiv Inc. (“Alimentiv”) is pleased to announce the appointment of Pierre Gaudreault as its Chief Executive Officer, effective January 2024. This announcement follows a search exhaustive survey of CEOs at an international level carried out by the board of directors.
Pierre brings a wealth of experience, with over 25 years of executive experience managing companies in Canada, Europe and Asia. His extensive experience includes international leadership roles in diverse business organizations, spearheading go-to-market model transformations and driving transformation and growth. He is deeply committed to fostering diversity and inclusion, building relationships, and promoting leadership development. His experience, coupled with commitment to a people-centered approach, aligns with the culture and values that are integral to Alimentiv. Pierre is well positioned to build on the strong foundation established by the leaders who preceded him.
“We are delighted to welcome Pierre as our new CEO. His extensive experience, strategic vision and commitment to relationships, diversity and inclusion align perfectly with Alimentiv’s values. Pierre’s deep experience will be invaluable to strategic vision and continued growth of the organization. We look forward to continued success under his leadership,” said Jennifer Roedding, Chairman of the Board of Directors of Alimentiv.
“In meeting with executives and the Board of Directors, I have admired how the entire company has been behind the mission of Transforming Human Health with people-focused values. I truly believe in teamwork and that together, as a collective group, “We can achieve tremendous results. I look forward to what we can achieve together,” said Pierre Gaudreault, incoming CEO of Alimentiv.
About Alimentiv Inc.
Alimentiv is a global contract research organization (CRO) focused on gastroenterology providing clinical trials, central image management, precision medicine, statistics and laboratory services to the pharmaceutical and biotechnology industries. Headquartered in London, Ontario, Alimentiv employs more than 500 people across its operations in Canada, the United States, Europe, Asia-Pacific and Latin America. The organization’s unique model combines the efforts of academic researchers and internationally recognized operational experts to deliver integrated solutions to clients. Over the past 20 years, Alimentiv has become a recognized expert in clinical trial design, central image management solutions, outcome measures development, and precision medicine for gastrointestinal drug development. Today, Alimentiv provides services in more than 50 countries worldwide, collaborates with leading universities and academic institutions around the world, and works with many leading pharmaceutical and biotechnology organizations to offer new and improved treatment options to patients. Alimentiv is committed to investing in medical research and development, focusing on identifying barriers to drug development and finding solutions that advance gastrointestinal research. Research findings are put into practice in an efficient clinical trial methodology for clients that aligns with emerging regulatory standards. In collaboration with leading experts, Alimentiv has pioneered the development, validation and standardization of technologies and outcome measures, shaping the evolving landscape of clinical trials for multiple indications and providing significant long-term consequences for patients, their treatment and society. For more information, visit: www.alimentiv.com
Contacto: Fern Livingstone, Tel: 519.639.3205, Email: fern.livingstone@alimentiv.com
Photo – https://mma.prnewswire.com/media/2312107…
View original content: https://www.prnewswire.com/news-releases/alimentiv-anuncia-a-pierre-gaudreault-como-nuevo-consejero-delegado-302027725.html
